MP66-02 SURVIVAL ANALYSIS OF PATIENTS WITH METASTATIC RENAL CELL CARCINOMA UNDERGOING CYTOREDUCTIVE NEPHRECTOMY WITH OR WITHOUT A NEOADJUVANT TYROSINE KINASE INHIBITOR

Cell Carcinoma ◽

Renal Cell ◽

Kinase Inhibitor ◽

Faculty Opinions recommendation of Does timing of cytoreductive nephrectomy impact patient survival with metastatic renal cell carcinoma in the tyrosine kinase inhibitor era? A multi-institutional study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717979900.793471988 ◽

2013 ◽

Author(s):

Hendrik van Poppel ◽

Yuri Tolkach

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Cell Carcinoma ◽

Renal Cell ◽

Kinase Inhibitor ◽

Patient Survival ◽

1776 DOES TIMING OF CYTOREDUCTIVE NEPHRECTOMY IMPACT PATIENT SURVIVAL WITH METASTATIC RENAL CELL CARCINOMA IN THE TYROSINE KINASE INHIBITOR ERA?

The Journal of Urology ◽

10.1016/j.juro.2011.02.2104 ◽

2011 ◽

Vol 185 (4S) ◽

Author(s):

Sean Stroup ◽

Omer Raheem ◽

Ryan Kopp ◽

Kerrin Palazzi-Churas ◽

Reza Mehrazin ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Cell Carcinoma ◽

Renal Cell ◽

Kinase Inhibitor ◽

Patient Survival ◽

Does Timing of Cytoreductive Nephrectomy Impact Patient Survival With Metastatic Renal Cell Carcinoma in the Tyrosine Kinase Inhibitor Era? A Multi-institutional Study

Urology ◽

10.1016/j.urology.2012.10.054 ◽

2013 ◽

Vol 81 (4) ◽

pp. 805-812 ◽

Cited By ~ 25

Author(s):

Sean P. Stroup ◽

Omer A. Raheem ◽

Kerrin L. Palazzi ◽

Michael A. Liss ◽

Reza Mehrazin ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Cell Carcinoma ◽

Renal Cell ◽

Kinase Inhibitor ◽

Patient Survival ◽

Impact of cytoreductive nephrectomy in patients with primary metastatic renal cell carcinoma receiving systemic tyrosine kinase inhibitor therapy: A multicenter retrospective study

International Journal of Urology ◽

10.1111/iju.14466 ◽

2020 ◽

Author(s):

Shingo Hatakeyama ◽

Sei Naito ◽

Kazuyuki Numakura ◽

Renpei Kato ◽

Tomoyuki Koguchi ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Retrospective Study ◽

Tyrosine Kinase ◽

Cell Carcinoma ◽

Renal Cell ◽

Kinase Inhibitor ◽

Cytoreductive Nephrectomy ◽

Tyrosine Kinase Inhibitor Therapy

A Case of Metastatic Renal Cell Carcinoma to the Maxillary Sinus Treated with Tyrosine Kinase Inhibitor

Korean Journal of Otorhinolaryngology - Head and Neck Surgery ◽

10.3342/kjorl-hns.2012.55.11.717 ◽

2012 ◽

Vol 55 (11) ◽

pp. 717 ◽

Cited By ~ 2

Author(s):

Young Hyo Kim ◽

Jae Eun Kim ◽

Sungmin Park ◽

Tae Young Jang

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Cell Carcinoma ◽

Maxillary Sinus ◽

Renal Cell ◽

Kinase Inhibitor

Long-term outcomes of tyrosine kinase inhibitor discontinuation in patients with metastatic renal cell carcinoma

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-015-2942-1 ◽

2015 ◽

Vol 77 (2) ◽

pp. 339-347 ◽

Cited By ~ 3

Author(s):

Dong-Hoe Koo ◽

Inkeun Park ◽

Jin-Hee Ahn ◽

Dae-Ho Lee ◽

Dalsan You ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Cell Carcinoma ◽

Tyrosine Kinase Inhibitor Discontinuation

Renal Cell ◽

Kinase Inhibitor ◽

Long Term Outcomes ◽

Influence of Prior Tyrosine Kinase Inhibitor on Survival for Patients with Metastatic Renal Cell Carcinoma Treated with Nivolumab or Cabozantinib: Data from a Literature-based Meta-analysis

European Urology ◽

10.1016/j.eururo.2017.07.019 ◽

2017 ◽

Vol 72 (6) ◽

pp. 1027-1028 ◽

Cited By ~ 1

Author(s):

Giandomenico Roviello ◽

Daniele Generali

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Cell Carcinoma ◽

Renal Cell ◽

Kinase Inhibitor ◽

Meta Analysis

The Adiponectin-AdipoR1 Axis Mediates Tumor Progression and Tyrosine Kinase Inhibitor Resistance in Metastatic Renal Cell Carcinoma

Neoplasia ◽

10.1016/j.neo.2019.07.004 ◽

2019 ◽

Vol 21 (9) ◽

pp. 921-931 ◽

Cited By ~ 1

Author(s):

Guangxi Sun ◽

Xingming Zhang ◽

Zhenhua Liu ◽

Sha Zhu ◽

Pengfei Shen ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Tumor Progression ◽

Cell Carcinoma ◽

Renal Cell ◽

Kinase Inhibitor ◽

Inhibitor Resistance

Cytoreductive Nephrectomy in Metastatic Clear‐Cell Renal Cell Carcinoma: Perspectives in the Tyrosine Kinase Inhibitor Era

The Oncologist ◽

10.1634/theoncologist.2008-0121 ◽

2009 ◽

Vol 14 (1) ◽

pp. 52-59 ◽

Cited By ~ 20

Author(s):

Swethajit Biswas ◽

John Kelly ◽

Tim Eisen

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Cell Carcinoma ◽

Renal Cell ◽

Kinase Inhibitor ◽

Clear Cell ◽

Cytoreductive Nephrectomy ◽

Cell Renal Cell Carcinoma

7108 Phase II study of IMC-1121B in patients with metastatic renal cell carcinoma (mRCC) following failure of VEGFR-2 tyrosine kinase inhibitor (TKI) therapy: interim results (IMCL CP12–0605/NCT00515697)

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(09)71441-7 ◽

2009 ◽

Vol 7 (2) ◽

pp. 425 ◽

Cited By ~ 7

Author(s):

J.A. Garcia ◽

G. Hudes ◽

T.K. Choueiri ◽

W.M. Stadler ◽

L. Wood ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Cell Carcinoma ◽

Phase Ii ◽

Renal Cell ◽

Kinase Inhibitor ◽

Phase Ii Study